South Texas Accelerated Research Therapeutics (START)

Site:	South Texas Accelerated Research Therapeutics (START)	Go to their website
Address:	4319 Medical Dr.
City:	San Antonio
State:	TX
Zip:	78229
Country:	USA

11 trials at this site

Phase	Trial [desc]	Trial Status	Site Status	Drug	NCT#
1	Study of the Safety and Pharmacokinetics of XL765 in Adults With Solid Tumors	Ongoing, but not recruiting	Closed	XL765	NCT00485719
1/2	Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors	Terminated	Closed	CB-839 + Talazoparib	NCT03875313
1	Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies	Ongoing, but not recruiting	Closed	MP470	NCT00894894
1	Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody	Active, not recruiting	Closed	HuF9-G4	NCT02216409
1	Phase 1 Study of CP-751,871 in Combination With Sunitinib in Patients With Advanced Solid Tumors	Ongoing, but not recruiting	Closed	Sunitinib + CP-751,871	NCT00729833
1	Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma	Ongoing, but not recruiting	Closed	ARQ 092	NCT01473095
1	Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors	Ongoing, but not recruiting	Closed	BIIB021 (CNF2024)	NCT00618735
1	MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma	Terminated	Closed	MP470	NCT00504205
1	Continuous Dosing of Regorafenib in Patients With Advanced Malignancies	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506)	NCT01117623
1	A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors	Active, not recruiting	Closed	PT2977	NCT02974738
1	A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors	Ongoing, but not recruiting	Closed	PLX3397 + Pembrolizumab	NCT02452424